These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 15180612)
21. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713 [TBL] [Abstract][Full Text] [Related]
22. Histologic grading of urothelial carcinoma: a reappraisal. Cheng L; MacLennan GT; Lopez-Beltran A Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126 [TBL] [Abstract][Full Text] [Related]
23. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345 [TBL] [Abstract][Full Text] [Related]
24. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma. Bircan S; Candir O; Serel TA Urol Int; 2004; 73(3):201-8. PubMed ID: 15539837 [TBL] [Abstract][Full Text] [Related]
25. Urothelial papilloma of the bladder. Clinical and biologic implications. Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437 [TBL] [Abstract][Full Text] [Related]
26. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses. Garbar C; Mascaux C; Wespes E Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491 [TBL] [Abstract][Full Text] [Related]
27. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP). Jones TD; Cheng L Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth. Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613 [TBL] [Abstract][Full Text] [Related]
29. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Lee TK; Chaux A; Karram S; Miyamoto H; Miller JS; Fajardo DA; Epstein JI; Netto GJ Hum Pathol; 2011 Nov; 42(11):1799-803. PubMed ID: 21777949 [TBL] [Abstract][Full Text] [Related]
30. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928 [TBL] [Abstract][Full Text] [Related]
31. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136 [TBL] [Abstract][Full Text] [Related]
32. Significance of denuded urothelium in papillary urothelial lesions. Owens CL; Epstein JI Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776 [TBL] [Abstract][Full Text] [Related]
34. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005 [TBL] [Abstract][Full Text] [Related]
35. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder. Roychowdhury A; Dey RK; Bandyapadhyay A; Bhattacharya P; Mitra RB; Dutta R J Indian Med Assoc; 2012 Jun; 110(6):393-6. PubMed ID: 23360043 [TBL] [Abstract][Full Text] [Related]
36. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Busch C; Algaba F Virchows Arch; 2002 Aug; 441(2):105-8. PubMed ID: 12189498 [TBL] [Abstract][Full Text] [Related]
37. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma. Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109 [TBL] [Abstract][Full Text] [Related]
38. [So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors]. Billerey C; Sibony M Ann Pathol; 2003 Feb; 23(1):21-33. PubMed ID: 12743497 [TBL] [Abstract][Full Text] [Related]
39. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Lane Z; Epstein JI Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418 [TBL] [Abstract][Full Text] [Related]
40. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder. Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]